Bernhard, Wolfgang http://orcid.org/0000-0003-0307-223X
Böckmann, Katrin
Maas, Christoph
Mathes, Michaela
Hövelmann, Julia
Shunova, Anna
Hund, Verena
Schleicher, Erwin
Poets, Christian F.
Franz, Axel R.
Funding for this research was provided by:
Medical Faculty, Eberhard Karls University, Tübingen (E.03.27032.1)
Article History
Received: 19 September 2018
Accepted: 28 February 2019
First Online: 11 March 2019
Compliance with ethical standards
:
: Axel Franz has received speaker or consultant honoraria from Nestlé, Milupa, and Hipp, all marketing infant formulas. Furthermore, Axel Franz has received grants from Nestlé for the conduct of educational seminars and for the conduct of a clinical study. Furthermore, Axel Franz and Wolfgang Bernhard have received consultant honoraria from Baxter and Fresenius Kabi, all marketing components of parenteral nutrition. All the other authors indicate they have no financial relationships relevant to this article.
: Based on current and previous work of this group, the University of Tuebingen, Medical Faculty, submitted a patent application for the combined administration of choline, ARA and DHA for prevention of developmental disorders associated with very preterm birth. The inventors of said patent application (WB, ARF) and all the other authors indicate that they do not have any conflict of interest to disclose.